Healthy Weight Loss Could Lower Your Odds for Cancer

25 Jun 2024
www.drugs.com
AHA
TUESDAY, June 25, 2024 -- Losing weight can protect you against cancers related to obesity, a new study finds.
Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.
But study results show that dropping pounds can improve a person’s odds against developing these cancers, including breast, kidney, ovary, liver and pancreatic cancers.
“This study reinforces how crucial it is to treat obesity as a chronic disease,” said researcher Dr. Kenda Alkwatli, a clinical fellow at Cleveland Clinic. “We are hopeful that these results can help us better understand how we can use weight loss to address co-morbidities, including cancer in patients with obesity.”
For the study, researchers evaluated the electronic health records of more than 100,000 obese patients at the Cleveland Clinic, of whom more than 5,300 developed cancer.
Researchers tracked changes in BMI at three-, five- and 10-year intervals prior to a person’s cancer diagnosis and compared them against controls.
They found that losing weight could reduce a person’s risk of developing most obesity-related cancers within a five-year span.
For example, the risk of kidney cancer dropped within three years and endometrial cancer at three and five years. Multiple myeloma risk fell within 10 years.
What’s more, losing weight also appeared to protect people against a range of 16 other cancers that haven’t been linked to obesity, researchers found.
These included melanoma and cancers of the skin, lungs, genitalia, eye, brain and digestive organs.
Researchers next intend to see if anti-obesity drugs like Wegovy and Zepbound can cut cancer risk.
The researchers presented their results Friday at the American Diabetes AssociationDiabetes Association’s annual meeting in Orlando, Fla. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.